Direct comparison of PI-RADS version 2 and version 1 regarding interreader agreement and diagnostic accuracy for the detection of clinically significant prostate cancer.
暂无分享,去创建一个
A. Becker | D. Eberli | O. Donati | D. Stocker | B. Barth | C. Reiner | E. Ulbrich | A. Mortezavi | A. Cornelius
[1] M. Benndorf,et al. Diagnostic performance and reproducibility of T2w based and diffusion weighted imaging (DWI) based PI-RADSv2 lexicon descriptors for prostate MRI. , 2017, European journal of radiology.
[2] Y. Huan,et al. A meta-analysis of use of Prostate Imaging Reporting and Data System Version 2 (PI-RADS V2) with multiparametric MR imaging for the detection of prostate cancer , 2017, European Radiology.
[3] C. Wassberg,et al. Quantification of metabolite concentrations in benign and malignant prostate tissues using 3D proton MR spectroscopic imaging , 2017, Journal of magnetic resonance imaging : JMRI.
[4] Carlos Nicolau,et al. Detection of Clinically Significant Prostate Cancer: Short Dual-Pulse Sequence versus Standard Multiparametric MR Imaging-A Multireader Study. , 2017, Radiology.
[5] Baris Turkbey,et al. Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study , 2017, Journal of magnetic resonance imaging : JMRI.
[6] F. Wacker,et al. Standardized Reporting of Prostate MRI: Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) Version 1 and Version 2 , 2016, PloS one.
[7] D. Nanz,et al. Comparison of image quality and patient discomfort in prostate MRI: pelvic phased array coil vs. endorectal coil , 2016, Abdominal Radiology.
[8] Bernd Hamm,et al. T2- and diffusion-weighted magnetic resonance imaging at 3T for the detection of prostate cancer with and without endorectal coil: An intraindividual comparison of image quality and diagnostic performance. , 2016, European journal of radiology.
[9] D. Georg,et al. Head-to-head comparison of PI-RADS v2 and PI-RADS v1. , 2016, European journal of radiology.
[10] H. Hricak,et al. Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference , 2016, European Radiology.
[11] Tobias Franiel,et al. Assessment of PI-RADS v2 for the Detection of Prostate Cancer. , 2016, European journal of radiology.
[12] Adam T Froemming,et al. Interobserver Reproducibility of the PI-RADS Version 2 Lexicon: A Multicenter Study of Six Experienced Prostate Radiologists. , 2016, Radiology.
[13] P L Choyke,et al. PI-RADS version 2: what you need to know. , 2015, Clinical radiology.
[14] Baris Turkbey,et al. Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging. , 2015, Radiology.
[15] M. Vannier,et al. Dynamic Contrast-enhanced MR Imaging Curve-type Analysis: Is It Helpful in the Differentiation of Prostate Cancer from Healthy Peripheral Zone? , 2015, Radiology.
[16] Peter L Choyke,et al. Modernizing the Diagnostic and Decision-Making Pathway for Prostate Cancer , 2014, Clinical Cancer Research.
[17] Jan van der Meulen,et al. Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard. , 2013, Radiology.
[18] M. Röthke,et al. PI-RADS-Klassifikation: Strukturiertes Befundungsschema für die MRT der Prostata , 2013, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.
[19] S. Schoenberg,et al. Interscanner Comparison of Dynamic Contrast-Enhanced MRI in Prostate Cancer: 1.5 Versus 3 T MRI , 2013, Investigative radiology.
[20] J. Fütterer,et al. ESUR prostate MR guidelines 2012 , 2012, European Radiology.
[21] Yipeng Hu,et al. Characterizing clinically significant prostate cancer using template prostate mapping biopsy. , 2011, The Journal of urology.
[22] Theodorus H van der Kwast,et al. The contemporary concept of significant versus insignificant prostate cancer. , 2011, European urology.
[23] A. Heidenreich. Consensus criteria for the use of magnetic resonance imaging in the diagnosis and staging of prostate cancer: not ready for routine use. , 2011, European urology.
[24] H. Hricak,et al. Interactive dedicated training curriculum improves accuracy in the interpretation of MR imaging of prostate cancer , 2010, European Radiology.
[25] N A Obuchowski,et al. Nonparametric analysis of clustered ROC curve data. , 1997, Biometrics.
[26] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[27] J. Fleiss,et al. Intraclass correlations: uses in assessing rater reliability. , 1979, Psychological bulletin.
[28] Jacob Cohen,et al. Weighted kappa: Nominal scale agreement provision for scaled disagreement or partial credit. , 1968 .
[29] D. Margolis,et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. , 2016, European urology.
[30] Thomas Hambrock,et al. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging. , 2013, Radiology.
[31] D. Cicchetti,et al. Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior. , 1981, American journal of mental deficiency.